This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Premenstrual Syndrome Treatment Market Size, Trends & Analysis - Forecasts to 2029 By Drug Type (Analgesics, Antidepressants, Oral Contraceptives & Ovarian Suppression Agents, and Others), By Type (Prescription and OTC), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global premenstrual syndrome (PMS) treatment market is estimated to exhibit a CAGR of 3.6% from 2024 to 2029.
The primary factors propelling the market growth are the increasing prevalence of premenstrual syndrome and rising women's health initiatives. The need for efficient PMS management solutions and hormonal imbalance remedies is growing as more people suffer from PMS symptoms. As a result of pharmaceutical firms' and healthcare providers' increased development and provision of a greater array of treatment choices specifically designed to cater to the various demands of PMS patients, the market is driven by this growing demand. Additionally, more people are aware of PMS and accept it as an actual medical condition. Due to this awareness, more people with symptoms are encouraged to get medical attention, which raises the prevalence that has been documented. For instance, around 90% of women in the United States who are of reproductive age have been reported to experience specific PMS symptoms at some point in their lives, according to Medscape (2024).
The emergence of telemedicine services, online health platforms, and supportive regulatory frameworks and policies are expected to support the market growth. With the availability of telemedicine services and online health platforms, individuals have easier access to healthcare professionals and information about PMS management, including natural PMS relief options and menstrual cycle support products. Furthermore, these platforms frequently work with wearable technology, smartphone apps, and online symptom trackers as examples of digital health solutions. These resources can assist patients in tracking their menstrual cycles, better understanding their symptoms, and assessing the efficacy of various treatment approaches.
The establishment of patient advocacy groups and the increasing coverage of women's health care under health insurance propel market growth. Due to increased insurance coverage, more individuals can access a broader range of healthcare services, including holistic PMS treatments and integrative PMS care approaches. Patients seeking complete PMS management face fewer financial obstacles owing to this enhanced coverage, which encourages them to consider treatment choices outside traditional pharmaceuticals.
There is a growing demand for symptom-specific PMS therapies that address specific PMS symptoms such as mood swings, bloating, fatigue, and cramps. Developing treatments that target these symptoms individually can provide more effective relief for patients. Additionally, with increasing interest in natural and holistic approaches to healthcare, the market for herbal supplements for PMS is expanding. There are opportunities for producers to create and market efficient herbal medicines as botanicals like chasteberry, evening primrose oil, and ginger demonstrate potential in reducing PMS symptoms.
However, the lack of standardized diagnosis and treatment guidelines and variability of symptoms hinder market growth.
The analgesics segment is expected to hold the largest share of the market over the forecast period. Menstrual cramps are a typical symptom of PMS, and analgesics, such as acetaminophen and nonsteroidal anti-inflammatory medications (NSAIDs), are used to treat the pain and discomfort associated with them. For many women seeking relief from menstruation discomfort, these are the supported options due to their widespread availability, effectiveness, and familiarity.
The antidepressants segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Antidepressants treat the emotional consequences of PMS, which are common in patients and include anxiety and mood problems. Their emphasis on mental wellness makes them a popular option among both patients and medical professionals.
The prescription segment is expected to hold the largest share of the market over the forecast period. Health authorities subject prescription drugs to stringent testing and regulation to guarantee their quality, safety, and efficacy. Patients and healthcare professionals both gain trust from this regulatory oversight, which promotes the general acceptance and use of prescription PMS therapies.
The over-the-counter (OTC) segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Within the OTC segment, non-pharmaceutical PMS interventions such as herbal supplements, vitamins, and dietary modifications are gaining popularity due to their perceived safety and natural approach to symptom management. Consumers seeking alternative or complementary treatments to traditional pharmaceuticals often turn to OTC options, driving the growth of this segment.
The drug stores & retail pharmacies segment is expected to hold the largest share of the market over the forecast period. The segment growth is attributed to drug stores and retail pharmacies offering easy access to treatment options for those looking for relief from their premenstrual syndrome (PMS) symptoms. Due to their simple accessibility and extensive local presence, they are the ideal distribution channel for PMS drugs.
The online pharmacies segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Online pharmacies break down geographical boundaries, giving people all around the world access to PMS treatment alternatives regardless of where they are. This global reach opens up new markets and makes it easier to get PMS drugs to underserved areas, driving the growth of the online pharmacies segment.
North America is expected to be the largest region in the global market. Growing awareness about premenstrual syndrome and its impact on women's health is driving the demand for effective treatment options in North America. Increased awareness promotes rapid treatment and diagnosis among the general public and healthcare professionals.
Asia Pacific is anticipated to witness rapid growth during the forecast period. With governments making investments in the construction of healthcare facilities and expanding healthcare services, the Asia Pacific region is witnessing a significant rise in its healthcare infrastructure. The diagnosis and treatment of PMS are improved by improved access to healthcare facilities and services, which propels market growth.
Bayer AG., Dr. Reddy’s Laboratories Ltd, Shionogi Inc., BASF Corporation, ABBVIE INC., GlaxoSmithKline Plc., Eli Lilly and Company, Pfizer Inc., AstraZeneca plc, and H. Lundbeck A/S, among others, are some of the key players operating in the global premenstrual syndrome treatment market.
Please note: This is not an exhaustive list of companies profiled in the report.
In September 2023, the late-stage clinical biopharmaceutical company Vistagen announced that one of its five experimental neuroactive nasal sprays, PH80, showed statistically significant improvement over placebo in an exploratory Phase 2A study for the acute management of premenstrual dysphoric disorder (PMDD) symptoms, including depressive mood and behavioral and physical symptoms.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET, BY DRUG TYPE
4.1 Introduction
4.2 Premenstrual Syndrome Treatment Market: Drug Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Analgesics
4.4.1 Analgesics Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Antidepressants
4.5.1 Antidepressants Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Oral Contraceptives & Ovarian Suppression Agents
4.6.1 Oral Contraceptives & Ovarian Suppression Agents Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Others
4.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET, BY TYPE
5.1 Introduction
5.2 Premenstrual Syndrome Treatment Market: Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Prescription
5.4.1 Prescription Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 OTC
5.5.1 OTC Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1 Introduction
6.2 Premenstrual Syndrome Treatment Market: Distribution Channel Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Hospital Pharmacies
6.4.1 Hospital Pharmacies Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Drug Stores & Retail Pharmacies
6.5.1 Drug Stores & Retail Pharmacies Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Online pharmacies
6.6.1 Online pharmacies Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET, BY REGION
7.1 Introduction
7.2 North America Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.1 By Drug Type
7.2.2 By Type
7.2.3 By Distribution Channel
7.2.4 By Country
7.2.4.1 U.S. Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.1.1 By Drug Type
7.2.4.1.2 By Type
7.2.4.1.3 By Distribution Channel
7.2.4.2 Canada Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.2.1 By Drug Type
7.2.4.2.2 By Type
7.2.4.2.3 By Distribution Channel
7.2.4.3 Mexico Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.3.1 By Drug Type
7.2.4.3.2 By Type
7.2.4.3.3 By Distribution Channel
7.3 Europe Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.1 By Drug Type
7.3.2 By Type
7.3.3 By Distribution Channel
7.3.4 By Country
7.3.4.1 Germany Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.1.1 By Drug Type
7.3.4.1.2 By Type
7.3.4.1.3 By Distribution Channel
7.3.4.2 U.K. Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.2.1 By Drug Type
7.3.4.2.2 By Type
7.3.4.2.3 By Distribution Channel
7.3.4.3 France Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.3.1 By Drug Type
7.3.4.3.2 By Type
7.3.4.3.3 By Distribution Channel
7.3.4.4 Italy Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.4.1 By Drug Type
7.3.4.4.2 By Type
7.2.4.4.3 By Distribution Channel
7.3.4.5 Spain Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.5.1 By Drug Type
7.3.4.5.2 By Type
7.2.4.5.3 By Distribution Channel
7.3.4.6 Netherlands Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.6.1 By Drug Type
7.3.4.6.2 By Type
7.2.4.6.3 By Distribution Channel
7.3.4.7 Rest of Europe Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.7.1 By Drug Type
7.3.4.7.2 By Type
7.2.4.7.3 By Distribution Channel
7.4 Asia Pacific Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.1 By Drug Type
7.4.2 By Type
7.4.3 By Distribution Channel
7.4.4 By Country
7.4.4.1 China Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.1.1 By Drug Type
7.4.4.1.2 By Type
7.4.4.1.3 By Distribution Channel
7.4.4.2 Japan Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.2.1 By Drug Type
7.4.4.2.2 By Type
7.4.4.2.3 By Distribution Channel
7.4.4.3 India Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.3.1 By Drug Type
7.4.4.3.2 By Type
7.4.4.3.3 By Distribution Channel
7.4.4.4 South Korea Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.4.1 By Drug Type
7.4.4.4.2 By Type
7.4.4.4.3 By Distribution Channel
7.4.4.5 Singapore Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.5.1 By Drug Type
7.4.4.5.2 By Type
7.4.4.5.3 By Distribution Channel
7.4.4.6 Malaysia Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.6.1 By Drug Type
7.4.4.6.2 By Type
7.4.4.6.3 By Distribution Channel
7.4.4.7 Thailand Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.7.1 By Drug Type
7.4.4.7.2 By Type
7.4.4.7.3 By Distribution Channel
7.4.4.8 Indonesia Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.8.1 By Drug Type
7.4.4.8.2 By Type
7.4.4.8.3 By Distribution Channel
7.4.4.9 Vietnam Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.9.1 By Drug Type
7.4.4.9.2 By Type
7.4.4.9.3 By Distribution Channel
7.4.4.10 Taiwan Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.10.1 By Drug Type
7.4.4.10.2 By Type
7.4.4.10.3 By Distribution Channel
7.4.4.11 Rest of Asia Pacific Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.11.1 By Drug Type
7.4.4.11.2 By Type
7.4.4.11.3 By Distribution Channel
7.5 Middle East and Africa Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.1 By Drug Type
7.5.2 By Type
7.5.3 By Distribution Channel
7.5.4 By Country
7.5.4.1 Saudi Arabia Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.1.1 By Drug Type
7.5.4.1.2 By Type
7.5.4.1.3 By Distribution Channel
7.5.4.2 U.A.E. Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.2.1 By Drug Type
7.5.4.2.2 By Type
7.5.4.2.3 By Distribution Channel
7.5.4.3 Israel Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.3.1 By Drug Type
7.5.4.3.2 By Type
7.5.4.3.3 By Distribution Channel
7.5.4.4 South Africa Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.4.1 By Drug Type
7.5.4.4.2 By Type
7.5.4.4.3 By Distribution Channel
7.5.4.5 Rest of Middle East and Africa Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.5.1 By Drug Type
7.5.4.5.2 By Type
7.5.4.5.2 By Distribution Channel
7.6 Central and South America Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.1 By Drug Type
7.6.2 By Type
7.6.3 By Distribution Channel
7.6.4 By Country
7.6.4.1 Brazil Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.1.1 By Drug Type
7.6.4.1.2 By Type
7.6.4.1.3 By Distribution Channel
7.6.4.2 Argentina Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.2.1 By Drug Type
7.6.4.2.2 By Type
7.6.4.2.3 By Distribution Channel
7.6.4.3 Chile Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.3.1 By Drug Type
7.6.4.3.2 By Type
7.6.4.3.3 By Distribution Channel
7.6.4.4 Rest of Central and South America Premenstrual Syndrome Treatment Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.4.1 By Drug Type
7.6.4.4.2 By Type
7.6.4.4.3 By Distribution Channel
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 Bayer AG.
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Dr. Reddy’s Laboratories Ltd
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Shionogi Inc.
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 BASF Corporation
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 ABBVIE INC.
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 GLAXOSMITHKLINE PLC.
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 Eli Lilly and Company
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Pfizer Inc.
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 AstraZeneca plc
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 H. Lundbeck A/S
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Type Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Mllion)
2 Analgesics Market, By Region, 2021-2029 (USD Mllion)
3 Antidepressants Market, By Region, 2021-2029 (USD Mllion)
4 Oral Contraceptives & Ovarian Suppression Agents Market, By Region, 2021-2029 (USD Mllion)
5 Others Market, By Region, 2021-2029 (USD Mllion)
6 Global Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Mllion)
7 Prescription Market, By Region, 2021-2029 (USD Mllion)
8 OTC Market, By Region, 2021-2029 (USD Mllion)
9 Global Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Mllion)
10 Hospital Pharmacies Market, By Region, 2021-2029 (USD Mllion)
11 Drug Stores & Retail Pharmacies Market, By Region, 2021-2029 (USD Mllion)
12 Online pharmacies Market, By Region, 2021-2029 (USD Mllion)
13 Regional Analysis, 2021-2029 (USD Mllion)
14 North America Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
15 North America Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
16 North America Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
17 North America Premenstrual Syndrome Treatment Market, By Country, 2021-2029 (USD Million)
18 U.S. Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
19 U.S. Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
20 U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
21 Canada Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
22 Canada Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
23 Canada Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
24 Mexico Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
25 Mexico Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
26 Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
27 Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
28 Europe Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
29 Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
30 Europe Premenstrual Syndrome Treatment Market, By Country 2021-2029 (USD Million)
31 Germany Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
32 Germany Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
33 Germany Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
34 U.K. Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
35 U.K. Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
36 U.K. Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
37 France Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
38 France Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
39 France Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
40 Italy Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
41 Italy Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
42 Italy Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
43 Spain Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
44 Spain Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
45 Spain Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
46 Netherlands Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
47 Netherlands Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
48 Netherlands Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
49 Rest Of Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
50 Rest Of Europe Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
51 Rest of Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
52 Asia Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
53 Asia Pacific Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
54 Asia Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
55 Asia Pacific Premenstrual Syndrome Treatment Market, By Country, 2021-2029 (USD Million)
56 China Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
57 China Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
58 China Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
59 India Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
60 India Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
61 India Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
62 Japan Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
63 Japan Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
64 Japan Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
65 South Korea Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
66 South Korea Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
67 South Korea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
68 malaysia Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
69 malaysia Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
70 malaysia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
71 Thailand Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
72 Thailand Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
73 Thailand Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
74 Indonesia Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
75 Indonesia Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
76 Indonesia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
77 Vietnam Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
78 Vietnam Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
79 Vietnam Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
80 Taiwan Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
81 Taiwan Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
82 Taiwan Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
83 Rest of Asia Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
84 Rest of Asia Pacific Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
85 Rest of Asia Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
86 Middle East and Africa Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
87 Middle East and Africa Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
88 Middle East and Africa Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
89 Middle East and Africa Premenstrual Syndrome Treatment Market, By Country, 2021-2029 (USD Million)
90 Saudi Arabia Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
91 Saudi Arabia Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
92 Saudi Arabia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
93 UAE Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
94 UAE Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
95 UAE Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
96 Israel Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
97 Israel Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
98 Israel Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
99 South Africa Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
100 South Africa Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
101 South Africa Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
102 Rest of Middle East and Africa Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
103 Rest of Middle East and Africa Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
104 Rest of Middle East and Africa Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
105 Central and South America Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
106 Central and South America Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
107 Central and South America Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
108 Central and South America Premenstrual Syndrome Treatment Market, By Country, 2021-2029 (USD Million)
109 Brazil Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
110 Brazil Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
111 Brazil Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
112 Argentina Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
113 Argentina Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
114 Argentina Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
115 Chile Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
116 Chile Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
117 Chile Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
118 Rest of Central and South America Premenstrual Syndrome Treatment Market, By Drug Type, 2021-2029 (USD Million)
119 Rest of Central and South America Premenstrual Syndrome Treatment Market, By Type, 2021-2029 (USD Million)
120 Rest of Central and South America Premenstrual Syndrome Treatment Market, By Distribution Channel, 2021-2029 (USD Million)
121 Bayer AG.: Products & Services Offering
122 Dr. Reddy’s Laboratories Ltd: Products & Services Offering
123 Shionogi Inc.: Products & Services Offering
124 BASF Corporation: Products & Services Offering
125 ABBVIE INC.: Products & Services Offering
126 GLAXOSMITHKLINE PLC.: Products & Services Offering
127 Eli Lilly and Company : Products & Services Offering
128 Pfizer Inc.: Products & Services Offering
129 AstraZeneca plc, Inc: Products & Services Offering
130 H. Lundbeck A/S: Products & Services Offering
131 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Premenstrual Syndrome Treatment Market Overview
2 Global Premenstrual Syndrome Treatment Market Value From 2021-2029 (USD Mllion)
3 Global Premenstrual Syndrome Treatment Market Share, By Drug Type (2023)
4 Global Premenstrual Syndrome Treatment Market Share, By Type (2023)
5 Global Premenstrual Syndrome Treatment Market Share, By Distribution Channel (2023)
6 Global Premenstrual Syndrome Treatment Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Premenstrual Syndrome Treatment Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Premenstrual Syndrome Treatment Market
11 Impact Of Challenges On The Global Premenstrual Syndrome Treatment Market
12 Porter’s Five Forces Analysis
13 Global Premenstrual Syndrome Treatment Market: By Drug Type Scope Key Takeaways
14 Global Premenstrual Syndrome Treatment Market, By Drug Type Segment: Revenue Growth Analysis
15 Analgesics Market, By Region, 2021-2029 (USD Mllion)
16 Antidepressants Market, By Region, 2021-2029 (USD Mllion)
17 Oral Contraceptives & Ovarian Suppression Agents Market, By Region, 2021-2029 (USD Mllion)
18 Others Market, By Region, 2021-2029 (USD Mllion)
19 Global Premenstrual Syndrome Treatment Market: By Type Scope Key Takeaways
20 Global Premenstrual Syndrome Treatment Market, By Type Segment: Revenue Growth Analysis
21 Prescription Market, By Region, 2021-2029 (USD Mllion)
22 OTC Market, By Region, 2021-2029 (USD Mllion)
23 Global Premenstrual Syndrome Treatment Market: By Distribution Channel Scope Key Takeaways
24 Global Premenstrual Syndrome Treatment Market, By Distribution Channel Segment: Revenue Growth Analysis
25 Hospital Pharmacies Market, By Region, 2021-2029 (USD Mllion)
26 Drug Stores & Retail Pharmacies Market, By Region, 2021-2029 (USD Mllion)
27 Online Pharmacies Market, By Region, 2021-2029 (USD Mllion)
28 Regional Segment: Revenue Growth Analysis
29 Global Premenstrual Syndrome Treatment Market: Regional Analysis
30 North America Premenstrual Syndrome Treatment Market Overview
31 North America Premenstrual Syndrome Treatment Market, By Drug Type
32 North America Premenstrual Syndrome Treatment Market, By Type
33 North America Premenstrual Syndrome Treatment Market, By Distribution Channel
34 North America Premenstrual Syndrome Treatment Market, By Country
35 U.S. Premenstrual Syndrome Treatment Market, By Drug Type
36 U.S. Premenstrual Syndrome Treatment Market, By Type
37 U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel
38 Canada Premenstrual Syndrome Treatment Market, By Drug Type
39 Canada Premenstrual Syndrome Treatment Market, By Type
40 Canada Premenstrual Syndrome Treatment Market, By Distribution Channel
41 Mexico Premenstrual Syndrome Treatment Market, By Drug Type
42 Mexico Premenstrual Syndrome Treatment Market, By Type
43 Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel
44 Four Quadrant Positioning Matrix
45 Company Market Share Analysis
46 Bayer AG.: Company Snapshot
47 Bayer AG.: SWOT Analysis
48 Bayer AG.: Geographic Presence
49 Dr. Reddy’s Laboratories Ltd: Company Snapshot
50 Dr. Reddy’s Laboratories Ltd: SWOT Analysis
51 Dr. Reddy’s Laboratories Ltd: Geographic Presence
52 Shionogi Inc.: Company Snapshot
53 Shionogi Inc.: SWOT Analysis
54 Shionogi Inc.: Geographic Presence
55 BASF Corporation: Company Snapshot
56 BASF Corporation: Swot Analysis
57 BASF Corporation: Geographic Presence
58 ABBVIE INC.: Company Snapshot
59 ABBVIE INC.: SWOT Analysis
60 ABBVIE INC.: Geographic Presence
61 GLAXOSMITHKLINE PLC.: Company Snapshot
62 GLAXOSMITHKLINE PLC.: SWOT Analysis
63 GLAXOSMITHKLINE PLC.: Geographic Presence
64 Eli Lilly and Company : Company Snapshot
65 Eli Lilly and Company : SWOT Analysis
66 Eli Lilly and Company : Geographic Presence
67 Pfizer Inc.: Company Snapshot
68 Pfizer Inc.: SWOT Analysis
69 Pfizer Inc.: Geographic Presence
70 AstraZeneca plc, Inc.: Company Snapshot
71 AstraZeneca plc, Inc.: SWOT Analysis
72 AstraZeneca plc, Inc.: Geographic Presence
73 H. Lundbeck A/S: Company Snapshot
74 H. Lundbeck A/S: SWOT Analysis
75 H. Lundbeck A/S: Geographic Presence
76 Other Companies: Company Snapshot
77 Other Companies: SWOT Analysis
78 Other Companies: Geographic Presence
The Global Premenstrual Syndrome Treatment Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Premenstrual Syndrome Treatment Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
